(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1323172 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ZMIZ1 mRNA CTD PMID:22079256 17beta-estradiol increases expression ISO RGD:1323172 6480464 Estradiol results in increased expression of ZMIZ1 mRNA CTD PMID:23019147 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of ZMIZ1 mRNA CTD PMID:32145629 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1323172 6480464 Dihydrotestosterone results in increased expression of ZMIZ1 mRNA CTD PMID:29581250 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1323172 6480464 Tetrachlorodibenzodioxin results in increased expression of ZMIZ1 mRNA CTD PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ZMIZ1 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1617978 6480464 Tetrachlorodibenzodioxin affects the expression of ZMIZ1 mRNA CTD PMID:21570461 , PMID:24680724 3,3',5-triiodo-L-thyronine increases expression ISO RGD:1323172 6480464 Triiodothyronine results in increased expression of ZMIZ1 mRNA CTD PMID:23397585 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1323172 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ZMIZ1 mRNA more ... CTD PMID:28628672 3-methylcholanthrene multiple interactions ISO RGD:1323172 6480464 Methylcholanthrene promotes the reaction [AHR protein binds to ZMIZ1 promoter] CTD PMID:20348232 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1323172 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ZMIZ1 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol affects methylation ISO RGD:1617978 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of ZMIZ1 gene CTD PMID:31683443 4,4'-sulfonyldiphenol increases methylation ISO RGD:1617978 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of ZMIZ1 exon CTD PMID:33297965 acetamide increases expression EXP 6480464 acetamide results in increased expression of ZMIZ1 mRNA CTD PMID:31881176 aflatoxin B1 decreases methylation ISO RGD:1323172 6480464 Aflatoxin B1 results in decreased methylation of ZMIZ1 gene CTD PMID:27153756 aflatoxin B1 increases methylation ISO RGD:1323172 6480464 Aflatoxin B1 results in increased methylation of ZMIZ1 3' UTR, Aflatoxin B1 results in increased methylation of ZMIZ1 intron CTD PMID:30157460 Aflatoxin B2 alpha affects methylation ISO RGD:1323172 6480464 aflatoxin B2 affects the methylation of ZMIZ1 intron CTD PMID:30157460 all-trans-retinoic acid increases expression ISO RGD:1323172 6480464 Tretinoin results in increased expression of ZMIZ1 mRNA CTD PMID:21934132 aristolochic acid A decreases expression ISO RGD:1323172 6480464 aristolochic acid I results in decreased expression of ZMIZ1 mRNA, aristolochic acid I results in decreased expression of ZMIZ1 protein CTD PMID:33212167 arsane affects methylation ISO RGD:1323172 6480464 Arsenic affects the methylation of ZMIZ1 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1323172 6480464 Arsenic affects the methylation of ZMIZ1 gene CTD PMID:25304211 arsenite(3-) multiple interactions ISO RGD:1323172 6480464 arsenite inhibits the reaction [G3BP1 protein binds to ZMIZ1 mRNA] CTD PMID:32406909 atrazine decreases expression ISO RGD:1323172 6480464 Atrazine results in decreased expression of ZMIZ1 mRNA CTD PMID:22378314 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of ZMIZ1 gene CTD PMID:28931070 benzo[a]pyrene affects expression ISO RGD:1323172 6480464 Benzo(a)pyrene affects the expression of ZMIZ1 mRNA CTD PMID:20106945 benzo[a]pyrene increases methylation ISO RGD:1323172 6480464 Benzo(a)pyrene results in increased methylation of ZMIZ1 promoter CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1323172 6480464 Benzo(a)pyrene affects the methylation of ZMIZ1 3' UTR more ... CTD PMID:27901495 , PMID:30157460 benzo[a]pyrene decreases expression ISO RGD:1323172 6480464 Benzo(a)pyrene results in decreased expression of ZMIZ1 mRNA CTD PMID:20064835 more ... benzo[a]pyrene decreases expression ISO RGD:1617978 6480464 Benzo(a)pyrene results in decreased expression of ZMIZ1 mRNA CTD PMID:19770486 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1323172 6480464 7 more ... CTD PMID:19150397 , PMID:20382639 benzo[e]pyrene increases methylation ISO RGD:1323172 6480464 benzo(e)pyrene results in increased methylation of ZMIZ1 3' UTR, benzo(e)pyrene results in increased methylation of ZMIZ1 intron CTD PMID:30157460 bis(2-chloroethyl) sulfide affects expression EXP 6480464 Mustard Gas affects the expression of ZMIZ1 mRNA CTD PMID:15651846 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ZMIZ1 mRNA CTD PMID:25181051 bisphenol A decreases methylation ISO RGD:1323172 6480464 bisphenol A results in decreased methylation of ZMIZ1 gene CTD PMID:31601247 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ZMIZ1 mRNA CTD PMID:32145629 bisphenol A multiple interactions ISO RGD:1323172 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of ZMIZ1 gene, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ZMIZ1 mRNA CTD PMID:28628672 , PMID:31601247 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of ZMIZ1 gene CTD PMID:28505145 bisphenol F multiple interactions ISO RGD:1323172 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ZMIZ1 mRNA CTD PMID:28628672 buta-1,3-diene decreases expression ISO RGD:1617978 6480464 1, 3-butadiene results in decreased expression of ZMIZ1 mRNA CTD PMID:29038090 butanal decreases expression ISO RGD:1323172 6480464 butyraldehyde results in decreased expression of ZMIZ1 mRNA CTD PMID:26079696 cadmium atom increases expression ISO RGD:1323172 6480464 Cadmium results in increased expression of ZMIZ1 mRNA CTD PMID:24376830 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of ZMIZ1 mRNA CTD PMID:18668222 choline multiple interactions ISO RGD:1617978 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ZMIZ1 gene CTD PMID:20938992 cisplatin decreases expression ISO RGD:1323172 6480464 Cisplatin results in decreased expression of ZMIZ1 mRNA CTD PMID:19561079 , PMID:27392435 copper(II) sulfate increases expression ISO RGD:1323172 6480464 Copper Sulfate results in increased expression of ZMIZ1 mRNA CTD PMID:19549813 coumestrol decreases expression ISO RGD:1323172 6480464 Coumestrol results in decreased expression of ZMIZ1 mRNA CTD PMID:19167446 crocidolite asbestos decreases expression ISO RGD:1323172 6480464 Asbestos, Crocidolite results in decreased expression of ZMIZ1 mRNA CTD PMID:29523930 crotonaldehyde decreases expression ISO RGD:1323172 6480464 2-butenal results in decreased expression of ZMIZ1 mRNA CTD PMID:20471460 cyclosporin A increases expression ISO RGD:1323172 6480464 Cyclosporine results in increased expression of ZMIZ1 mRNA CTD PMID:20106945 cyclosporin A decreases expression ISO RGD:1323172 6480464 Cyclosporine results in decreased expression of ZMIZ1 mRNA CTD PMID:25562108 , PMID:27989131 deguelin decreases expression ISO RGD:1323172 6480464 deguelin results in decreased expression of ZMIZ1 mRNA CTD PMID:33512557 dexamethasone multiple interactions ISO RGD:1323172 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ZMIZ1 mRNA more ... CTD PMID:28628672 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of ZMIZ1 mRNA CTD PMID:21266533 dicrotophos increases expression ISO RGD:1323172 6480464 dicrotophos results in increased expression of ZMIZ1 mRNA CTD PMID:28302478 diuron decreases expression EXP 6480464 Diuron results in decreased expression of ZMIZ1 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:1323172 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZMIZ1 mRNA CTD PMID:27188386 epoxiconazole decreases expression ISO RGD:1617978 6480464 epoxiconazole results in decreased expression of ZMIZ1 mRNA CTD PMID:35436446 ethanol decreases expression ISO RGD:1617978 6480464 Ethanol results in decreased expression of ZMIZ1 mRNA CTD PMID:29018328 ethanol increases expression ISO RGD:1617978 6480464 Ethanol results in increased expression of ZMIZ1 mRNA CTD PMID:30319688 ethanol affects splicing ISO RGD:1617978 6480464 Ethanol affects the splicing of ZMIZ1 mRNA CTD PMID:30319688 folic acid multiple interactions ISO RGD:1617978 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ZMIZ1 gene CTD PMID:20938992 folic acid decreases expression ISO RGD:1617978 6480464 Folic Acid results in decreased expression of ZMIZ1 mRNA CTD PMID:25629700 formaldehyde decreases expression ISO RGD:1323172 6480464 Formaldehyde results in decreased expression of ZMIZ1 mRNA CTD PMID:17938736 fulvestrant increases methylation ISO RGD:1323172 6480464 Fulvestrant results in increased methylation of ZMIZ1 gene CTD PMID:31601247 fulvestrant multiple interactions ISO RGD:1323172 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of ZMIZ1 gene CTD PMID:31601247 genistein increases expression ISO RGD:1617978 6480464 Genistein results in increased expression of ZMIZ1 mRNA CTD PMID:32186404 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of ZMIZ1 mRNA CTD PMID:22061828 geraniol increases expression ISO RGD:1323172 6480464 geraniol results in increased expression of ZMIZ1 mRNA CTD PMID:27683099 indometacin multiple interactions ISO RGD:1323172 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ZMIZ1 mRNA more ... CTD PMID:28628672 inulin multiple interactions ISO RGD:1617978 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ZMIZ1 mRNA CTD PMID:36331819 L-methionine multiple interactions ISO RGD:1617978 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ZMIZ1 gene CTD PMID:20938992 lead(0) affects splicing ISO RGD:1323172 6480464 Lead affects the splicing of ZMIZ1 mRNA CTD PMID:28903495 leflunomide increases expression ISO RGD:1323172 6480464 leflunomide results in increased expression of ZMIZ1 mRNA CTD PMID:28988120 menadione affects expression ISO RGD:1323172 6480464 Vitamin K 3 affects the expression of ZMIZ1 mRNA CTD PMID:20044591 methapyrilene increases methylation ISO RGD:1323172 6480464 Methapyrilene results in increased methylation of ZMIZ1 3' UTR, Methapyrilene results in increased methylation of ZMIZ1 intron CTD PMID:30157460 methidathion increases expression ISO RGD:1617978 6480464 methidathion results in increased expression of ZMIZ1 mRNA CTD PMID:34813904 methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of ZMIZ1 gene CTD PMID:35440735 methylmercury chloride increases expression ISO RGD:1323172 6480464 methylmercuric chloride results in increased expression of ZMIZ1 mRNA CTD PMID:23179753 , PMID:26272509 methylmercury chloride multiple interactions ISO RGD:1323172 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZMIZ1 mRNA CTD PMID:27188386 N-ethyl-N-nitrosourea increases mutagenesis ISO RGD:1617978 6480464 Ethylnitrosourea results in increased mutagenesis of ZMIZ1 intron CTD PMID:27776689 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of ZMIZ1 mRNA CTD PMID:25729387 paracetamol increases expression ISO RGD:1323172 6480464 Acetaminophen results in increased expression of ZMIZ1 mRNA CTD PMID:29067470 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of ZMIZ1 mRNA CTD PMID:33387578 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1617978 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ZMIZ1 mRNA CTD PMID:36331819 phenobarbital affects expression ISO RGD:1617978 6480464 Phenobarbital affects the expression of ZMIZ1 mRNA CTD PMID:23091169 picoxystrobin decreases expression ISO RGD:1323172 6480464 picoxystrobin results in decreased expression of ZMIZ1 mRNA CTD PMID:33512557 potassium chromate multiple interactions ISO RGD:1323172 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ZMIZ1 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:1323172 6480464 potassium chromate(VI) results in decreased expression of ZMIZ1 mRNA CTD PMID:22079256 pyrimidifen decreases expression ISO RGD:1323172 6480464 pyrimidifen results in decreased expression of ZMIZ1 mRNA CTD PMID:33512557 raloxifene affects expression ISO RGD:1323172 6480464 Raloxifene Hydrochloride affects the expression of ZMIZ1 mRNA CTD PMID:14699072 raloxifene multiple interactions ISO RGD:1323172 6480464 [Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of ZMIZ1 mRNA CTD PMID:19059307 rotenone decreases expression ISO RGD:1323172 6480464 Rotenone results in decreased expression of ZMIZ1 mRNA CTD PMID:33512557 SB 431542 multiple interactions ISO RGD:1323172 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZMIZ1 mRNA CTD PMID:27188386 silver atom decreases expression ISO RGD:1617978 6480464 Silver results in decreased expression of ZMIZ1 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1617978 6480464 Silver results in decreased expression of ZMIZ1 mRNA CTD PMID:27131904 sodium arsenate decreases expression ISO RGD:1617978 6480464 sodium arsenate results in decreased expression of ZMIZ1 mRNA CTD PMID:21795629 tamoxifen multiple interactions ISO RGD:1323172 6480464 [Tamoxifen co-treated with ESR2 protein] results in decreased expression of ZMIZ1 mRNA CTD PMID:19059307 tamoxifen affects expression ISO RGD:1323172 6480464 Tamoxifen affects the expression of ZMIZ1 mRNA CTD PMID:14699072 temozolomide decreases expression ISO RGD:1323172 6480464 Temozolomide results in decreased expression of ZMIZ1 mRNA CTD PMID:31758290 tert-butyl hydroperoxide increases expression ISO RGD:1323172 6480464 tert-Butylhydroperoxide results in increased expression of ZMIZ1 mRNA CTD PMID:15336504 testosterone increases expression ISO RGD:1323172 6480464 Testosterone results in increased expression of ZMIZ1 mRNA CTD PMID:33359661 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of ZMIZ1 mRNA CTD PMID:31150632 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of ZMIZ1 mRNA CTD PMID:34492290 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of ZMIZ1 mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of ZMIZ1 mRNA CTD PMID:25729387 trichostatin A decreases expression ISO RGD:1323172 6480464 trichostatin A results in decreased expression of ZMIZ1 mRNA CTD PMID:27188386 triptonide affects expression ISO RGD:1617978 6480464 triptonide affects the expression of ZMIZ1 mRNA CTD PMID:33045310 tungsten decreases expression ISO RGD:1617978 6480464 Tungsten results in decreased expression of ZMIZ1 mRNA CTD PMID:30912803 valproic acid affects expression ISO RGD:1617978 6480464 Valproic Acid affects the expression of ZMIZ1 mRNA CTD PMID:17963808 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of ZMIZ1 mRNA CTD PMID:29427782 valproic acid increases expression ISO RGD:1323172 6480464 Valproic Acid results in increased expression of ZMIZ1 mRNA CTD PMID:24935251 valproic acid decreases expression ISO RGD:1323172 6480464 Valproic Acid results in decreased expression of ZMIZ1 mRNA CTD PMID:29154799 versicolorin A decreases expression ISO RGD:1323172 6480464 versicolorin A results in decreased expression of ZMIZ1 mRNA CTD PMID:32106047 vorinostat decreases expression ISO RGD:1323172 6480464 vorinostat results in decreased expression of ZMIZ1 mRNA CTD PMID:27188386
